Archives for November 1, 2004

← 2004

Microfluidics makes short work of emulsions

Emulsions are widely used in the formulation of pharmaceuticals, cosmetics and foods, and researchers are continually striving to increase the complexity of emulsions as a delivery vehicle.

Virtual room makes knowledge out of data

A team at Purdue University in the US is developing a virtual 'data cave' for scientific discovery that uses high-performance computing and artificial intelligence software to display information and interact with researchers.

Cambrex makes €33m third quarter loss

Cambrex has recorded a loss in the third quarter of this year after writing down goodwill in its biopharma division in a move that paints a pessimistic picture of the market for outsourced manufacturing of biological drugs.

Capital investment news round-up

European companies have announced hefty spending on new manufacturing facilities this month, suggesting that despite a difficult operating environment the pharmaceutical sector is still prepared to make significant capital investments

Collaboration aims at improved insulin pump

Animas has entered into a license and development agreement with Debiotech, which aims to develop the next generation of insulin pumps and micro needles using Debiotech's Micro Electromechanical Systems (MEMS) microfluidic technology.

New technique blocks Alzheimer's plaque build-up

A new therapeutic technique based on a small molecule working in tandem with a larger protein has been shown to block accumulation of the brain-clogging amyloid protein seen in Alzheimer's disease, raising the possibility of a new effective drug...